Skip to Main Content

Paper Details

Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses.
Sci Transl Med
79
2022
Beta, Delta, and Omicron variants, D614, Omicron, Omicron variant, SARS, SARS-CoV, SARS-CoV-2, VSV, mRNA, severe acute respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus 2, spike protein, vesicular stomatitis, vesicular stomatitis virus, women
Author NameAffiliation
Prabhu S ArunachalamInstitute for Immunity, Stanford University School of Medicine
Scott D BoydStanford University School of Medicine
Scott D BoydSean N. Parker Center for Allergy and Asthma Research
Mark M DavisInstitute for Immunity, Stanford University School of Medicine
Mark M DavisHoward Hughes Medical Institute, Stanford University School of Medicine
Mark M DavisStanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University School of Medicine
Bali PulendranInstitute for Immunity, Stanford University School of Medicine
Richard H ScheuermannJ. Craig Venter Institute
Richard H ScheuermannUniversity of California
Richard H ScheuermannJ. Craig Venter Institute
Richard H ScheuermannUniversity of California
Matthew B FriemanCenter for Pathogen Research, University of Maryland School of Medicine
Matthew B FriemanCenter for Pathogen Research, University of Maryland School of Medicine
  • 1 - 14

Datasets

Release 1.2